Article

Hepatectomy combined with targeted and immunotherapy for CNLC stage IIIb hepatocellular carcinoma: a single-arm clinical trials protocol

2022-07-31

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Introduction</h4> Current clinical guidelines recommend systematic antitumor therapy as the primary treatment option for patients with stage IIIb hepatocellular carcinoma (HCC) based on the China liver cancer staging (CNLC) criteria. Several different targeted therapeutics have been applied in combination with immunotherapeutic regimens to date in patients with advanced HCC. The present study...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 98c9448f-95d3-506c-9cf6-908c52b6142f
DOI: 10.1101/2022.07.29.22278175

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Hepatectomy combined with targeted and immunotherapy for CNLC stage IIIb hepatocellular carcinoma: a single-arm clinical trials protocolDOI 10.1101/2022.07.29.22278175Read

Developing targeted therapeutics for hepatocellular carcinoma: a critical assessment of promising phase II agents.Semantic proximity Read

Tackling hepatocellular carcinoma with individual or combinatorial immunotherapy approaches.Semantic proximity Read

Survival Analysis of TACE Monotherapy vs. Combination Therapy in BCLC B and C Stage Hepatocellular Carcinoma: A Retrospective Cohort StudySemantic proximity Read

Efficacy and safety of first-line EGFR-TKI combined with chemotherapy versus EGFR-TKI monotherapy in patients with EGFR-mutant non-small cell lung cancer and liver metastases: A propensity score-matched analysis.Semantic proximity Read

Notable-HCC: A phase Ib trial of neoadjuvant tislelizumab with stereotactic body radiotherapy in patients with early stage resectable hepatocellular carcinomaSemantic proximity Read

Causes of Death in Hepatocellular Carcinoma Patients: A SEER-Based StudySemantic proximity Read

Toripalimab combined with anlotinib as the second-line treatment for advanced hepatocellular carcinoma patients: a prospective, single arm phase II clinical studySemantic proximity Read

International Liver Cancer Association (ILCA) white paper on hepatocellular carcinoma risk stratification and surveillanceSemantic proximity Read

Exploration of Practical Biomarkers for Systemic Drug Therapy for Hepatocellular CarcinomaSemantic proximity Read

Clinicopathological features and prognosis of dual-phenotype hepatocellular carcinoma after curative hepatectomy: A propensity score matching analysis.Semantic proximity Read

Patient Outcomes in Resected Combined Hepatocellular Cholangiocarcinoma (cHCC-ICC) and Intrahepatic Cholangiocarcinoma: A Single Center StudySemantic proximity Read

Chemotherapy and targeted therapy for advanced biliary tract cancers：An umbrella reviewSemantic proximity Read